Program

6
6
1
1

Journal Year Published

4
3
1
1
5

Author

14
201
181
149
139
133
133
125
123
108
105
95
82
78
63
62
54
50
46
43
43

Category

6
3
3
1

Keyword

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Journal

2
2
1
1
1
1
1
1
1
1
1
1

NCATS Publications

Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments.


Wei D, Yang Y, Ricketts CJ, Vocke CD, Ball M, Sourbier C, Wangsa D, Wangsa D, Guha R, Zhang X, Wilson K, Chen L, Meltzer PS, Ried T, Thomas C, Merino MJ, Linehan WM


Genes Chromosomes Cancer , 2020.

Article Pubmed

Targeting AML-associated FLT3 mutations with a type I kinase inhibitor.


Jones LM, Melgar K, Bolanos L, Hueneman K, Walker MM, Jiang J, Wilson K, Zhang X, Shen J, Jiang F, Sutter P, Wang A, Xu X, Tawa G, Hoyt S, Wunderlich M, O'Brien E, Perentesis JP, Starczynowski DT, Thomas C


J. Clin. Invest. , (130), 2017-2023, 2020.

Article Pubmed

Sample image from publication page

Anxiolytic Drug FGIN-1-27 Ameliorates Autoimmunity by Metabolic Reprogramming of Pathogenic Th17 Cells.


Singh A, Dashnyam M, Chim B, Escobar TM, Dulcey AE, Hu X, Wilson K, Koganti PP, Spinner CA, Xu X, Jadhav A, Southall N, Marugan J, Selvaraj V, Lazarevic V, Muljo SA, Ferrer-Alegre M


Sci Rep , (10), 3766, 2020.

Article Pubmed

Sample image from publication page

Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening.


Lin GL, et al.


Sci Transl Med , (11), 2019.

Article Pubmed

Sample image from publication page

Overcoming adaptive therapy resistance in AML by targeting immune response pathways.


Melgar K, Walker MM, Jones LM, Bolanos LC, Hueneman K, Wunderlich M, Jiang J, Wilson K, Zhang X, Sutter P, Wang A, Xu X, Choi K, Tawa G, Lorimer D, Abendroth J, O'Brien E, Hoyt S, Berman E, Famulare CA, Mulloy JC, Levine RL, Perentesis JP, Thomas C, Starczynowski DT


Sci Transl Med , (11), 2019.

Article Pubmed

Sample image from publication page

High-throughput screening identifies candidate drugs for the treatment of recurrent respiratory papillomatosis.


Alkhilaiwi F, Paul S, Zhou D, Zhang X, Wang F, Palechor-Ceron N, Wilson K, Guha R, Ferrer-Alegre M, Grant N, Thomas C, Schlegel R, Yuan H


Papillomavirus Res , (8), 100181, 2019.

Article Pubmed

Sample image from publication page

Mutation Profiles in Glioblastoma 3D Oncospheres Modulate Drug Efficacy.


Wilson K, Mathews-Griner LA, Williamson T, Guha R, Chen L, Shinn P, McKnight C, Michael S, Klumpp-Thomas C, Binder ZA, Ferrer-Alegre M, Gallia GL, Thomas C, Riggins GJ


SLAS Technol , 2472630318803749, 2018.

Article Pubmed

Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma.


Heske CM, Davis MI, Baumgart JT, Wilson K, Gormally MV, Chen L, Zhang X, Ceribelli M, Duveau D, Guha R, Ferrer-Alegre M, Arnaldez FI, Ji J, Tran HL, Zhang Y, Mendoza A, Helman LJ, Thomas C


Clin. Cancer Res. , 2017.

Article Pubmed

Sample image from publication page

Large-scale pharmacological profiling of 3D tumor models of cancer cells.


Mathews Griner LA, Zhang X, Guha R, McKnight C, Goldlust IS, Lal-Nag M, Wilson K, Michael S, Titus S, Shinn P, Thomas C, Ferrer-Alegre M


Cell Death Dis , (7), e2492, 2016.

Article Pubmed

Sample image from publication page